Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2026-05-14 @ 1:29 PM
Study NCT ID:
NCT05925803
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2023-06-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D3460C00002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None